NurExone Biologic Inc. Announces Fourth Quarter and Full-Year 2024 Financial Results and Provides Corporate Update
TORONTO and HAIFA, Israel, April 10, 2025 (GLOBE NEWSWIRE) -- NurExone Biologic…
Silynxcom Ltd. Announces Closing of Public Offering
April 02, 2025 17:14 ET | Source: Silynxcom Ltd. Netanya, Israel, April…
Alma introduces Alma Harmony, a state-of-the-art aesthetic platform for next-level in-office treatments
Featuring a simply intelligence interface and substantial technological upgrades, the new multiplatform…
Sygnia Discovers New Active China-Nexus Threat Actor Weaver Ant
Incident Response leader reveals Weaver Ant leveraged home routers to target top…
SaverOne Reports Full Year 2024 Results
PETAH TIKVAH, Israel, March 21, 2025 (GLOBE NEWSWIRE) -- SaverOne 2014 Ltd.…
Wearable Devices Announces Full Year 2024 Financial Results and Provides Corporate Update
YOKNE’AM ILLIT, Israel, March 19, 2025 (GLOBE NEWSWIRE) -- Wearable Devices Ltd.…
Enlivex Receives Notice of Allowance for Chinese Patent Application Covering the Use of Allocetra in Patients with Osteoarthritis
March 17, 2025 08:00 ET | Source: Enlivex Therapeutics Ltd Nes-Ziona, Israel,…
CYREBRO’s AI-Native MDR Platform Earns Silver at the 2025 Globee Cybersecurity Awards
TEL AVIV, Israel, March 17, 2025 (GLOBE NEWSWIRE) -- CYREBRO, the AI-native…
ExoPTEN Preclinical Study Demonstrates Significant Potential for Enhancing Motor Function, Blood Flow, and Spinal Cord Injury Recovery
TORONTO and HAIFA, Israel, March 14, 2025 (GLOBE NEWSWIRE) -- NurExone Biologic…
Polyrizon Signs Non Binding LOI to Expand its Innovative Intranasal Drug Delivery Platform for Psychedelic-Based Treatments
March 14, 2025 08:35 ET | Source: Polyrizon Ltd. Raanana, Israel, March…